BI 730357
Drug timelines are a Plus or Pro feature.
12 regulatory and trial events tracked for BI 730357, covering 2022-06-02 to 2023-09-21. Get the full timeline:
Most recent: Clinical Trial Update: This Study Tests How Healthy Men Tolerate Different Doses of BI 730357 and How the Metabolism of Midazolam is Affected by BI 730357 [Phase 1]